Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Pilot Study of Nivolumab in Pediatric Patients with Hypermutant Cancers
Protocol ID
OZM-075 (Hypermutant Cancer)
Disease (Sub Disease)
All Tumour Types
Diagnosis Stage
Relapse/ refractory
Location
QLD, VIC, SA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
The Hospital for Sick Children
Collaborators
Bristol-Myers Squibb
Trial Status
Open
Sites
Queensland Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Study Type
Treatment
Phase
Pilot
Age Eligibility
12 months to 25 years
International registry ID's
NCT02992964
Back to Registry
Study Title Pilot Study of Nivolumab in Pediatric Patients with Hypermutant Cancers
Protocol ID OZM-075 (Hypermutant Cancer)
Disease (Sub Disease) All Tumour Types
Diagnosis Stage Relapse/ refractory
Location QLD / VIC / SA
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children
Collaborators Bristol-Myers Squibb
Links https://clinicaltrials.gov/ct2/show/study/NCT02992964
Trial Status Open
Trial Open Date 06/12/2019
Sites Queensland Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital
Study Type Treatment
Phase Pilot
Age Eligibility 12 months to 25 years
International registry ID's NCT02992964